CELC Celcuity Inc.
$96.38 +0.06%
Updated
Healthcare · Services-Medical Laboratories
Celcuity Inc. (CELC) is a healthcare company in the Services-Medical Laboratories industry, with a market capitalization of $4.7 billion. Shares last traded at $96.38, 36.2% below their 52-week high. Over the past year the stock is up 77.8%.
Market Cap
$4.7B
Shares Out
48.9M
EPS (TTM)
$-8.09
P/E Ratio
—
P/S Ratio
—
P/B Ratio
—
Dividend / Share
—
Dividend Yield
—
52-Week High
$151.06
52-Week Low
$44.73
Volume
50,438
Avg Vol (3m)
73,021.651
Performance
1W
+3.37%
1M
+3.77%
3M
+4.23%
6M
-16.38%
YTD
-4.05%
1Y
+77.79%
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
RSI (14)
55.86
SMA (50)
$94.41
SMA (200)
$106.21
Price vs SMA50
+2.09%
Price vs SMA200
-9.25%
ATR (14)
$4.99
Financials
Revenue
—
Net Income
$-226M
Gross Margin
—
Operating Margin
—
Net Margin
—
Return on Equity
1772.0%
Return on Assets
-27.3%
Current Ratio
8.93
Debt / Equity
0.00
Revenue Growth (YoY)
—
Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $-2.41 | 2026-08-13 |
| Q1 2026 | $-0.97 | 2026-05-14 |
| FY 2025 | $-3.79 | 2026-03-26 |
| Q3 2025 | $-2.81 | 2025-11-13 |
| Q2 2026 | $-1.90 | 2026-08-13 |
| Q1 2026 | $-0.86 | 2026-05-14 |
Services-Medical Laboratories peers
CELC vs 14 industry peers (Services-Medical Laboratories), by market cap. Updated
1–14 of 14
| NTRA | Natera, Inc. | $47.2B | -245.26 | 17.43 | -7.1% | +0.66% |
| LH | Labcorp | $26.9B | 26.82 | 1.87 | 7.0% | -0.07% |
| DGX | Quest Diagnostics | $26.4B | 24.88 | 2.29 | 9.2% | -0.58% |
| GH | Guardant Health, Inc. | $21.6B | -47.65 | 18.26 | -38.3% | -1.23% |
| CAI | Caris Life Sciences, Inc. | $7.2B | 68.06 | 7.23 | 10.6% | +2.14% |
| RDNT | Radnet, Inc. | $5.9B | -278.18 | 2.59 | -0.9% | -1.36% |
| CELC | Celcuity Inc. | $4.7B | -20.82 | — | — | +0.06% |
| BLLN | Billiontoone, Inc. | $4.6B | 121.86 | 11.56 | 9.5% | +3.64% |
| GRAL | Grail, Inc. | $3.6B | -9.19 | — | — | +0.03% |
| VCYT | Veracyte, Inc. | $3.6B | 31.35 | 6.39 | 20.4% | -0.65% |
| CDNA | Caredx, Inc. | $2.6B | 23.22 | 5.63 | 24.2% | +0.44% |
| PSNL | Personalis, Inc. | $1.8B | -16.77 | — | — | +0.51% |
| FTRE | Fortrea Holdings Inc. | $1.8B | -20.77 | 0.66 | -3.2% | +1.47% |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.1B | — | — | — | -1.53% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.